US Stock MarketDetailed Quotes
DRMAW DERMATA THERAPEUTICS INC C/WTS (TO PUR COM)
- 0.0147
- 0.00000.00%
Close Jul 19 16:00 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0147Open0.0147Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.029052wk High0.00P/B0Float Cap0.007052wk Low--Dividend TTM0Shs Float1.7000Historical High--Div YieldTTM0.00%Amplitude0.0050Historical Low--Avg Price1Lot Size
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 40.65%3.2M | -16.88%8.04M | 29.69%2.22M | -25.92%1.81M | -36.55%1.73M | -18.25%2.28M | 23.13%9.67M | -32.95%1.71M | 42.86%2.45M | 105.31%2.73M |
| Selling and administrative expenses | 47.72%1.6M | -1.28%3.97M | 31.89%1.08M | 1.82%909K | -20.08%893.48K | -8.84%1.09M | -8.51%4.02M | -42.94%822.33K | -2.16%892.78K | 141.59%1.12M |
| -General and administrative expense | 47.72%1.6M | -1.28%3.97M | 31.89%1.08M | 1.82%909K | -20.08%893.48K | -8.84%1.09M | -8.51%4.02M | -42.94%822.33K | -2.16%892.78K | 141.59%1.12M |
| Research and development costs | 34.22%1.6M | -27.98%4.07M | 27.65%1.14M | -41.87%902.98K | -47.97%838.93K | -25.27%1.19M | 63.36%5.65M | -20.01%889.36K | 94.22%1.55M | 85.95%1.61M |
| Operating profit | -40.65%-3.2M | 16.88%-8.04M | -29.69%-2.22M | 25.92%-1.81M | 36.55%-1.73M | 18.25%-2.28M | -23.13%-9.67M | 32.95%-1.71M | -42.86%-2.45M | -105.31%-2.73M |
| Net non-operating interest income expense | 84.60%69.3K | 288.87%247.22K | 104.00%85.86K | 331.76%92.77K | 31.05K | 37.54K | 239.37%63.57K | 42.09K | 3,400.46%21.49K | 0 |
| Non-operating interest income | 84.60%69.3K | 288.87%247.22K | 104.00%85.86K | 331.76%92.77K | --31.05K | --37.54K | --63.57K | --42.09K | --21.49K | --0 |
| Other net income (expense) | ||||||||||
| Income before tax | -39.91%-3.13M | 18.90%-7.79M | -27.81%-2.13M | 29.09%-1.72M | 37.69%-1.7M | 19.60%-2.24M | -21.62%-9.61M | 34.60%-1.67M | -41.55%-2.42M | -105.03%-2.73M |
| Income tax | ||||||||||
| Net income | -39.91%-3.13M | 18.90%-7.79M | -27.81%-2.13M | 29.09%-1.72M | 37.69%-1.7M | 19.60%-2.24M | -21.62%-9.61M | 34.60%-1.67M | -41.55%-2.42M | -105.03%-2.73M |
| Net income continuous Operations | -39.91%-3.13M | 18.90%-7.79M | -27.81%-2.13M | 29.09%-1.72M | 37.69%-1.7M | 19.60%-2.24M | -21.62%-9.61M | 34.60%-1.67M | -41.55%-2.42M | -105.03%-2.73M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -39.91%-3.13M | 18.90%-7.79M | -27.81%-2.13M | 29.09%-1.72M | 37.69%-1.7M | 19.60%-2.24M | -21.62%-9.61M | 34.60%-1.67M | -41.55%-2.42M | -105.03%-2.73M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -39.91%-3.13M | 18.90%-7.79M | -27.81%-2.13M | 29.09%-1.72M | 37.69%-1.7M | 19.60%-2.24M | 8.16%-9.61M | 34.60%-1.67M | 43.29%-2.42M | -105.03%-2.73M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg